mbiomics GmbH
Johannes B. Woehrstein is the CTO & Founder of mbiomics GmbH, where Johannes B. aims to revolutionize microbiome research, diagnostics, and therapeutics. Johannes B. is also a Non Executive Director at Invitris and the Managing Director & Founder of DEOXY. With a background in physics and biophysics, Johannes has held various positions at prestigious institutions like Harvard University and Max Planck Institute for Biochemistry, showcasing their expertise in research and technology development within the field.
mbiomics GmbH
We founded mbiomics to improve peoples lives by providing a novel approach to fully understand the secrets of the microbiome with the goal to better inform targeted therapies and how to lead a healthy life.